Document is current
Any future updates will be listed below
-
Authors
Tommasin, Silvia http://orcid.org/0000-0001-9088-7968
Cocozza, Sirio http://orcid.org/0000-0002-0300-5160
Taloni, Alessandro http://orcid.org/0000-0002-8863-7166
Giannì, Costanza http://orcid.org/0000-0002-4018-169X
Petsas, Nikolaos http://orcid.org/0000-0001-7150-9697
Pontillo, Giuseppe http://orcid.org/0000-0001-5425-1890
Petracca, Maria http://orcid.org/0000-0001-9429-2769
Ruggieri, Serena http://orcid.org/0000-0001-5287-3290
De Giglio, Laura http://orcid.org/0000-0001-9018-7320
Pozzilli, Carlo http://orcid.org/0000-0002-6360-4798
Brunetti, Arturo http://orcid.org/0000-0001-7057-3494
Pantano, Patrizia http://orcid.org/0000-0001-9659-8294
-
Funding
Funding for this research was provided by:
Fondazione Italiana Sclerosi Multipla (FISM/2018/S/3)
Università degli Studi di Roma La Sapienza
- License Information
-
More Information
Article History
Received: 16 December 2020
Revised: 5 May 2021
Accepted: 5 May 2021
First Online: 10 May 2021
Declarations
:
: ST, AT, CG, GP, AB have nothing to disclose. SC: received speaker fees from Sanofi and Amicus Therapeutics. NP: received speaker fees from Biogen and mission support from Genzyme and Novartis. MP: received travel funding from Novartis. SR: received speaking honoraria from Teva, Merck Serono, and Biogen, a travel grant from Biogen and Merck Serono, and a fee as an advisory board consultant from Merck Serono and Novartis. LDG: received fees as invited speaker or travel expenses for attending meeting from Biogen, Merck Serono and Novartis. CP: received consulting and lecture fees from Sanofi-Aventis, Biogen Idec, Bayer Schering, Merck Serono, and Novartis, research funding from Novartis, Sanofi-Aventis, Merck Serono, and Bayer Schering. PP: received founding for travel from Novartis, Genzyme and Bracco and speaker honoraria from Biogen.
: Study protocols were approved by the ethical committee of Policlinico Umberto I/Sapienza University (Rome, Italy, Site 1) and Ethics Committee for Biomedical Activities “Carlo Romano” of Federico II University (Naples, Italy, Site 2) as appropriate.
: All subjects provided written informed consent.
